By analyzing melanoma tumor biopsies that relapsed after PD-1 treatment, acquired homozygous loss-of-function mutations were identified in the kinases associated with the interferon-gamma receptor pathway: Janus kinase 1 (JAK1) and Janus kinase 2 (JAK2). Here, JAK2 is linked to melanoma.